155 related articles for article (PubMed ID: 31540689)
1. Estradiol regulation of P-glycoprotein expression in mouse kidney and human tubular epithelial cells, implication for renal clearance of drugs.
Kanado Y; Tsurudome Y; Omata Y; Yasukochi S; Kusunose N; Akamine T; Matsunaga N; Koyanagi S; Ohdo S
Biochem Biophys Res Commun; 2019 Nov; 519(3):613-619. PubMed ID: 31540689
[TBL] [Abstract][Full Text] [Related]
2. The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure.
Wang C; Li H; Luo C; Li Y; Zhang Y; Yun D; Mu D; Zhou K; Hua Y
Placenta; 2015 Oct; 36(10):1138-47. PubMed ID: 26311557
[TBL] [Abstract][Full Text] [Related]
3. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo.
Chow EC; Durk MR; Cummins CL; Pang KS
J Pharmacol Exp Ther; 2011 Jun; 337(3):846-59. PubMed ID: 21421739
[TBL] [Abstract][Full Text] [Related]
4. Recombinant interleukin-2 treatment decreases P-glycoprotein activity and paclitaxel metabolism in mice.
Bonhomme-Faivre L; Pelloquin A; Tardivel S; Urien S; Mathieu MC; Castagne V; Lacour B; Farinotti R
Anticancer Drugs; 2002 Jan; 13(1):51-7. PubMed ID: 11914641
[TBL] [Abstract][Full Text] [Related]
5. Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse.
Petropoulos S; Gibb W; Matthews SG
Placenta; 2010 Sep; 31(9):803-10. PubMed ID: 20655586
[TBL] [Abstract][Full Text] [Related]
6. Prenatal endotoxemia and placental drug transport in the mouse: placental size-specific effects.
Bloise E; Bhuiyan M; Audette MC; Petropoulos S; Javam M; Gibb W; Matthews SG
PLoS One; 2013; 8(6):e65728. PubMed ID: 23762418
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ecto-5'-nucleotidase promotes P-glycoprotein expression in renal epithelial cells.
Ledoux S; Leroy C; Siegfried G; Prie D; Moullier P; Friedlander G
Kidney Int; 1997 Oct; 52(4):953-61. PubMed ID: 9328934
[TBL] [Abstract][Full Text] [Related]
8. Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse.
Kawaguchi H; Matsui Y; Watanabe Y; Takakura Y
J Pharmacol Exp Ther; 2004 Jan; 308(1):91-6. PubMed ID: 14569074
[TBL] [Abstract][Full Text] [Related]
9. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
Schmitt C; Kaeser B; Riek M; Bech N; Kreuzer C
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):192-9. PubMed ID: 20197013
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of renal P-glycoprotein expression in mice: correlation with digoxin renal clearance.
Pinto N; Halachmi N; Verjee Z; Woodland C; Klein J; Koren G
Pediatr Res; 2005 Dec; 58(6):1284-9. PubMed ID: 16306209
[TBL] [Abstract][Full Text] [Related]
11. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
Zhang H; Yao M; Morrison RA; Chong S
Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
[TBL] [Abstract][Full Text] [Related]
12. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
Woodland C; Ito S; Koren G
Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells.
Taur JS; DesJardins CS; Schuck EL; Wong YN
Xenobiotica; 2011 Apr; 41(4):320-6. PubMed ID: 21162698
[TBL] [Abstract][Full Text] [Related]
14. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
[TBL] [Abstract][Full Text] [Related]
15. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
[TBL] [Abstract][Full Text] [Related]
16. Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1).
Ito S; Koren G; Harper PA; Silverman M
Can J Physiol Pharmacol; 1993 Jan; 71(1):40-7. PubMed ID: 8099844
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model.
Ito S; Woodland C; Harper PA; Koren G
Life Sci; 1993; 53(2):PL25-31. PubMed ID: 8100040
[TBL] [Abstract][Full Text] [Related]
18. RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene.
Omata Y; Yamauchi T; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
J Biol Chem; 2021; 296():100601. PubMed ID: 33781748
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).
Ito S; Woodland C; Harper PA; Koren G
Life Sci; 1993; 53(24):PL399-403. PubMed ID: 8246676
[TBL] [Abstract][Full Text] [Related]
20. Characterization of P-glycoprotein orthologs from human, sheep, pig, dog, and cat.
Azimi M; Yee SW; Riselli A; Silva DB; Giacomini CP; Giacomini KM; Brett CM
J Vet Pharmacol Ther; 2023 Nov; 46(6):401-412. PubMed ID: 37198956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
